Moteur de recherche d’entreprises européennes
Registre de Transparence de l'Union Européenne Eutr 17/10/2026 Registre de Transparence de l'Union Européenne
Vue d’ensemble
Texte
Merck
Registration Date: 2009-07-28 Last Update Date: 2026-06-01 Identification Code: 49654992078-52 Entity Form: KGaA Website: https://www.merckgroup.com/en Registration Category: Companies & groups
Head Office
- Address: Frankfurter Strasse 250, 64293 Darmstadt , GERMANY
- Phone: +49 6151720
EU Office
- Address:
?? Rue sans nom, 1040 Brüssel, Allemagne , BELGIUM - Phone: +32 477884843
Goals
Merck, a leading science and technology company, generated total revenues of €22.2 billion in 2022 with its divisions Healthcare, Electronics and Life Science. More than 64,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent stakes, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are the United States and Canada. Here Merck operates as EMD Serono in the Biopharma business, MilliporeSigma in the Life Science business, and as EMD Performance Materials in the Performance Materials/Electronics business.
Levels of Interest
- European
- Global
- Sub-national
- National
EU Legislative Proposals
Clean Industrial Deal, EU Economic Security Strategy, EU Competitiveness, Single Market Completion and all relevant policies/initiatives such as: Chemicals Strategy for Sustainability - REACH revision, Industrial Emissions Directive, Clean Air and Water, Fit-for-55, CLP regulation, Circular Economy policies, PFAS, CBAM Raw-Materials Act Digital Policies (i.e. EU Chips-Act, EU AI Act, EHDS) Trade policies (eg Global Gateway, customs regulations, TTC developments) Sustainable Finance (eg Taxonomy) Omnibuses for simplification Pharmaceutical Strategy and Health Care related policies. Intellectual Property (IP) Package Life Science related policies such as Medicinal Products Directive. Alternative approached to Animal testing Sanctions Packages on Russia etc.
EU Supported Forums and Platforms
Activities in the policy areas of Pharma and Health legislation, Energy and Climate, Environment and Chemicals legislations, Biotechnology, Chips, AI and data regulations, Taxation, Sustainable Finance, Research and Development - through our Trade Associations. Merck is committed to work in partnership with the European bodies to support policies and actions that facilitates patient access to treatments for unmet medical needs, especially chronic and rare diseases, as well as aspects supporting European R&D in innovative healthcare technologies - through our Trade Associations. Merck participates to the European Partnership for Alternative Approaches to Animal testing (EPAA).
Communication Activities
2024: Sponsoring of a Talk in Brussels on the topic of EU Competitiveness, with representatives of EU parliament, EU Commission and other stakeholders.
Inter or Unofficial Groupings
N/A
Members
- Total Members: 10.0
- FTE Members: 4.45
- Accredited to European Parliament: 4
Interests
- Budget
- Business and industry
- Climate action
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Environment
- External relations
- Foreign affairs and security policy
- Institutional affairs
- International co-operation and development
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
Structure
- Is Member Of: see above
- Organisation Members: Merck is a member of CEFIC (EU), EFPIA (EU), EBE - European Biopharmaceutical Enterprises (EU), EuropaBio, BVAC (DE with EU-office), VCI (DE) and its sub-state organisations such as LV Hessen, and DIB (Deutsche Industrievereinigung Biotechnologie), Bundesverband der deutschen Industrie (BDI), Verband forschender Arzneimittelhersteller (DE), World Economic Forum (WEF), Bitkom (DE), European Round Table for Industry (ERT), Cosmetics Europe, EUCCC (European Chamber of Commerce), ACATECH and various other sectoral organisations mainly at respective national/regional levels in the countries such as European General Counsel Association (UK), European Process Safety Center (UK), European Centre for Ecotoxicology and Toxicology of Chemicals (BE), European Partnership for Alternative Approaches to Animal testing (EPAA)
Interest Represented
Promotes their own interests or the collective interests of their members
Financial Data
New Organisation: No
Closed Year (2024-01-01 to 2024-12-01)
- Total Costs: €1,750,000 - €1,999,999
- Grants: None
Intermediaries
| Name | Representation Costs (€) |
|---|---|
| Harwood Levitt Consulting | 25,000 - 49,999 |
| FIPRA International SRL | 25,000 - 49,999 |
| NOVE | 50,000 - 99,999 |
| euractiv | 10,000 - 24,999 |
| HARMON CORPORATE AFFAIRS, SL | < 10,000 |
Current Year
- Grants: None
Intermediaries
- FIPRA International SRL
- HARMON CORPORATE AFFAIRS, SL
- NOVE
Complementary Information
Costs increased in 2024 due to the high number of important files that required more work with EU Institutions (General Pharmaceutical Legislation, Green Deal, PFAS, Chips and AI,...), and post-election intensive activities.
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : MERCK KGaA, Darmstadt, Allemagne.